{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:48:03Z","timestamp":1783774083496,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,3,12]],"date-time":"2016-03-12T00:00:00Z","timestamp":1457740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00701-016-2762-z","type":"journal-article","created":{"date-parts":[[2016,3,12]],"date-time":"2016-03-12T05:06:15Z","timestamp":1457759175000},"page":"933-942","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Reasons and results of endoscopic surgery for prolactinomas: 142 surgical cases"],"prefix":"10.1007","volume":"158","author":[{"given":"Safak","family":"Akin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkay","family":"Isikay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Figen","family":"Soylemezoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taskin","family":"Yucel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"Gurlek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Berker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,12]]},"reference":[{"key":"2762_CR1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4158\/EP09221.OR","volume":"16","author":"SV Acharya","year":"2010","unstructured":"Acharya SV, Gopal RA, Menon PS, Bandgar TR, Shah NS (2010) Giant prolactinoma and effectiveness of medical treatment. Endocr Pract 16:42\u201346","journal-title":"Endocr Pract"},{"key":"2762_CR2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11102-014-0588-3","volume":"18","author":"MH Almalki","year":"2015","unstructured":"Almalki MH, Buhary B, Alzahrani S, Alshahrani F, Alsherbeni S, Alhowsawi G, Aljohani N (2015) Giant prolactinomas: clinical manifestations and outcomes of 16 Arab cases. Pituitary 18:405\u2013409","journal-title":"Pituitary"},{"key":"2762_CR3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3171\/jns.2002.97.2.0307","volume":"97","author":"AP Amar","year":"2002","unstructured":"Amar AP, Couldwell WT, Chen JC, Weiss MH (2002) Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery. J Neurosurg 97:307\u2013314","journal-title":"J Neurosurg"},{"key":"2762_CR4","doi-asserted-by":"crossref","unstructured":"Amit Kumar Thotakura AK, Mohana Rao Patibandla MR, Manas K. Panigrahi MK, Gokul Chowdary Addagada GC (2015) Predictors of visual outcome with transsphenoidal excision of pituitary adenomas having suprasellar extension: a prospective series of 100 cases and brief review of the literature. Asian J Neurosurg. doi:10.4103\/1793-5482.149995","DOI":"10.4103\/1793-5482.149995"},{"key":"2762_CR5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11102-010-0283-y","volume":"14","author":"M Babey","year":"2010","unstructured":"Babey M, Sahli R, Vajtai I, Andres RH, Seiler RW (2010) Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists. Pituitary 14:222\u2013230","journal-title":"Pituitary"},{"key":"2762_CR6","first-page":"818","volume":"82","author":"AS Bates","year":"1997","unstructured":"Bates AS, Farrell WE, Bicknell EJ, McNicol AM, Talbot AJ, Broome JC, Perrett CW, Thakker RV, Clayton RN (1997) Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J Clin Endocrinol Metab 82:818\u2013824","journal-title":"J Clin Endocrinol Metab"},{"key":"2762_CR7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF03349742","volume":"18","author":"M Berezin","year":"1995","unstructured":"Berezin M, Shimon I, Hadani M (1995) Prolactinoma in 53 men: clinical characteristics and modes of treatment (male prolactinoma). J Endocrinol Investig 18:436\u2013441","journal-title":"J Endocrinol Investig"},{"key":"2762_CR8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11102-011-0368-2","volume":"15","author":"M Berker","year":"2012","unstructured":"Berker M, Hazer DB, Yucel T, Gurlek A, Cila A, Aldur M, Onerci M (2012) Complications of endoscopic surgery of the pituitary adenomas: analysis of 570 patients and review of the literature. Pituitary 15:288\u2013300","journal-title":"Pituitary"},{"key":"2762_CR9","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3171\/2014.6.JNS131994","volume":"121","author":"S Berkmann","year":"2014","unstructured":"Berkmann S, Schlaffer S, Nimsky C, Fahlbusch R, Buchfelder M (2014) Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma. J Neurosurg 121:1166\u20131175","journal-title":"J Neurosurg"},{"key":"2762_CR10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nec.2015.03.007","volume":"26","author":"P Cappabianca","year":"2015","unstructured":"Cappabianca P, Cavallo LM, de Divitiis O, de Angelis M, Chiaramonte C, Solari D (2015) Endoscopic endonasal extended approaches for the management of large pituitary adenomas. Neurosurg Clin N Am 26:323\u2013331","journal-title":"Neurosurg Clin N Am"},{"key":"2762_CR11","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.2174\/1871527311211080011","volume":"11","author":"R Carija","year":"2012","unstructured":"Carija R, Vucina D (2012) Frequency of pituitary tumor apoplexy during treatment of prolactinomas with dopamine agonists: a systematic review. CNS Neurol Disord Drug Targets 11:1012\u20131014","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2762_CR12","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM197810192991602","volume":"299","author":"JN Carter","year":"1978","unstructured":"Carter JN, Tyson JE, Tolis G, Van Vliet S, Faiman C, Friesen HG (1978) Prolactin-screening tumors and hypogonadism in 22 men. N Engl J Med 299:847\u2013852","journal-title":"N Engl J Med"},{"issue":"4","key":"2762_CR13","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.wneu.2015.06.007","volume":"84","author":"JD Chabot","year":"2015","unstructured":"Chabot JD, Chakraborty S, Imbarrato G, Dehdashti AR (2015) Evaluation of outcomes after endoscopic Endonasal surgery for large and giant pituitary Macroadenoma: a retrospective review of 39 consecutive patients. World Neurosurg 84(4):978\u2013988","journal-title":"World Neurosurg"},{"key":"2762_CR14","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.jocn.2013.02.027","volume":"20","author":"E Chng","year":"2013","unstructured":"Chng E, Dalan R (2013) Pituitary apoplexy associated with cabergoline therapy. J Clin Neurosci 20:1637\u20131643","journal-title":"J Clin Neurosci"},{"key":"2762_CR15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3340\/jkns.2008.44.3.151","volume":"44","author":"JH Choe","year":"2008","unstructured":"Choe JH, Lee KS, Jeun SS, Cho JH, Hong YK (2008) Endocrine outcome of endoscopic endonasal transsphenoidal surgery in functioning pituitary adenomas. J Korean Neurosurg Soc 44:151\u2013155","journal-title":"J Korean Neurosurg Soc"},{"key":"2762_CR16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11102-005-5079-0","volume":"8","author":"A Ciccarelli","year":"2005","unstructured":"Ciccarelli A, Daly AF, Beckers A (2005) The epidemiology of prolactinomas. Pituitary 8:3\u20136","journal-title":"Pituitary"},{"key":"2762_CR17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/eje.0.1480325","volume":"148","author":"A Colao","year":"2003","unstructured":"Colao A, Sarno AD, Cappabianca P, Briganti F, Pivonello R, Somma CD, Faggiano A, Biondi B, Lombardi G (2003) Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. Eur J Endocrinol 148:325\u2013331","journal-title":"Eur J Endocrinol"},{"key":"2762_CR18","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1365-2265.2003.01770.x","volume":"58","author":"SM Corsello","year":"2003","unstructured":"Corsello SM, Ubertini G, Altomare M, Lovicu RM, Migneco MG, Rota CA, Colosimo C (2003) Giant prolactinomas in men: efficacy of cabergoline treatment. Clin Endocrinol 58:662\u2013670","journal-title":"Clin Endocrinol"},{"key":"2762_CR19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2265.2009.03665.x","volume":"72","author":"MA Paiva Neto de","year":"2010","unstructured":"de Paiva Neto MA, Vandergrift A, Fatemi N, Gorgulho AA, Desalles AA, Cohan P, Wang C, Swerdloff R, Kelly DF (2010) Endonasal transsphenoidal surgery and multimodality treatment for giant pituitary adenomas. Clin Endocrinol 72:512\u2013519","journal-title":"Clin Endocrinol"},{"key":"2762_CR20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1227\/01.NEU.0000339121.20101.85","volume":"64","author":"AR Dehdashti","year":"2009","unstructured":"Dehdashti AR, Ganna A, Witterick I, Gentili F (2009) Expanded endoscopic endonasal approach for anterior cranial base and suprasellar lesions: indications and limitations. Neurosurgery 64:677\u2013687","journal-title":"Neurosurgery"},{"key":"2762_CR21","first-page":"2102","volume":"82","author":"E Delgrange","year":"1997","unstructured":"Delgrange E, Trouillas J, Maiter D, Donckier J, Tourniaire J (1997) Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J Clin Endocrinol Metab 82:2102\u20132107","journal-title":"J Clin Endocrinol Metab"},{"key":"2762_CR22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/jnnp.2004.035576","volume":"76","author":"KK Gnanalingham","year":"2005","unstructured":"Gnanalingham KK, Bhattacharjee S, Pennington R, Ng J, Mendoza N (2005) The time course of visual field recovery following transphenoidal surgery for pituitary adenomas: predictive factors for a good outcome. J Neurol Neurosurg Psychiatry 76:415\u2013419","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2762_CR23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1530\/eje.1.02339","volume":"156","author":"A Gurlek","year":"2007","unstructured":"Gurlek A, Karavitaki N, Ansorge O, Wass JA (2007) What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and genetics. Eur J Endocrinol 156:143\u2013153","journal-title":"Eur J Endocrinol"},{"key":"2762_CR24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.0954-6820.1985.tb01642.x","volume":"217","author":"AL Hulting","year":"1985","unstructured":"Hulting AL, Muhr C, Lundberg PO, Werner S (1985) Prolactinomas in men: clinical characteristics and the effect of bromocriptine treatment. Acta Med Scand 217:101\u2013109","journal-title":"Acta Med Scand"},{"key":"2762_CR25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s11102-011-0359-3","volume":"15","author":"RJ Komotar","year":"2012","unstructured":"Komotar RJ, Starke RM, Raper DM, Anand VK, Schwartz TH (2012) Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of giant pituitary adenomas. Pituitary 15:150\u2013159","journal-title":"Pituitary"},{"key":"2762_CR26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00401-005-1111-8","volume":"111","author":"G Kontogeorgos","year":"2006","unstructured":"Kontogeorgos G, Horvath E, Kovacs K, Coire C, Lloyd RV, Scheithauer BW, Smyth HS (2006) Morphologic changes of prolactin-producing pituitary adenomas after short treatment with dopamine agonists. Acta Neuropathol 111:46\u201352","journal-title":"Acta Neuropathol"},{"key":"2762_CR27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-07-0248","volume":"158","author":"J Kreutzer","year":"2008","unstructured":"Kreutzer J, Buslei R, Wallaschofski H, Hofmann B, Nimsky C, Fahlbusch R, Buchfelder M (2008) Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur J Endocrinol 158:11\u201318","journal-title":"Eur J Endocrinol"},{"key":"2762_CR28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1227\/00006123-198903000-00020","volume":"24","author":"MJ Kupersmith","year":"1989","unstructured":"Kupersmith MJ, Kleinberg D, Warren FA, Budzilovitch G, Cooper P (1989) Growth of prolactinoma despite lowering of serum prolactin by bromocriptine. Neurosurgery 24:417\u2013423","journal-title":"Neurosurgery"},{"key":"2762_CR29","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1210\/jcem-58-6-1179","volume":"58","author":"AM Landolt","year":"1984","unstructured":"Landolt AM, Osterwalder V (1984) Perivascular fibrosis in prolactinomas: is it increased by bromocriptine? J Clin Endocrinol Metab 58:1179\u20131183","journal-title":"J Clin Endocrinol Metab"},{"key":"2762_CR31","volume":"16","author":"JK Liu","year":"2004","unstructured":"Liu JK, Couldwell WT (2004) Contemporary management of prolactinomas. Neurosurg Focus 16, E2","journal-title":"Neurosurg Focus"},{"key":"2762_CR32","volume-title":"Pituitary tumors: introduction. World Health Organization classification of tumours. Pathology and genetics of tumours of endocrine organs","author":"RK Lloyd","year":"2004","unstructured":"Lloyd RK, Young WF Jr, Farrel WE, Asa SL, Trouillas J, Kontogeorgeos G, Sano T, Scheithauer BW, Horvath E (2004) Pituitary tumors: introduction. World Health Organization classification of tumours. Pathology and genetics of tumours of endocrine organs. IARC Press, Lyon"},{"key":"2762_CR33","doi-asserted-by":"crossref","first-page":"R213","DOI":"10.1530\/EJE-14-0013","volume":"170","author":"D Maiter","year":"2014","unstructured":"Maiter D, Delgrange E (2014) Therapy of endocrine disease: the challenges in managing giant prolactinomas. Eur J Endocrinol 170:R213\u2013R227","journal-title":"Eur J Endocrinol"},{"key":"2762_CR34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ando.2012.03.024","volume":"73","author":"D Maiter","year":"2012","unstructured":"Maiter D, Primeau V (2012) 2012 update in the treatment of prolactinomas. Ann Endocrinol 73:90\u201398","journal-title":"Ann Endocrinol"},{"key":"2762_CR35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1009943700810","volume":"2","author":"CH Martin","year":"1999","unstructured":"Martin CH, Schwartz R, Jolesz F, Black PM (1999) Transsphenoidal resection of pituitary adenomas in an intraoperative MRI unit. Pituitary 2:155\u2013162","journal-title":"Pituitary"},{"key":"2762_CR36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2265.1994.tb02557.x","volume":"41","author":"T Mindermann","year":"1994","unstructured":"Mindermann T, Wilson CB (1994) Age-related and gender-related occurrence of pituitary adenomas. Clin Endocrinol 41:359\u2013364","journal-title":"Clin Endocrinol"},{"key":"2762_CR37","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11060-013-1270-8","volume":"117","author":"ME Molitch","year":"2014","unstructured":"Molitch ME (2014) Management of medically refractory prolactinoma. J Neurooncol 117:421\u2013428","journal-title":"J Neurooncol"},{"key":"2762_CR38","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1210\/jcem.82.4.3845","volume":"82","author":"ME Molitch","year":"1997","unstructured":"Molitch ME, Thorner MO, Wilson C (1997) Management of prolactinomas. J Clin Endocrinol Metab 82:996\u20131000","journal-title":"J Clin Endocrinol Metab"},{"key":"2762_CR39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1530\/eje.0.1350413","volume":"135","author":"I Morange","year":"1996","unstructured":"Morange I, Barlier A, Pellegrini I, Brue T, Enjalbert A, Jaquet P (1996) Prolactinomas resistant to bromocriptine: long term efficacy of quanoglide and outcome of pregnancy. Eur J Endocrinol 135:413\u2013420","journal-title":"Eur J Endocrinol"},{"key":"2762_CR40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jocn.2010.04.049","volume":"18","author":"N Nakao","year":"2011","unstructured":"Nakao N, Itakura T (2011) Surgical outcome of the endoscopic endonasal approach for non-functioning giant pituitary adenoma. J Clin Neurosci 18:71\u201375","journal-title":"J Clin Neurosci"},{"key":"2762_CR42","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1210\/jc.2009-1191","volume":"95","author":"G Raverot","year":"2010","unstructured":"Raverot G, Wierinckx A, Dantony E, Auger C, Chapas G, Villeneuve L, Brue T, Figarella-Branger D, Roy P, Jouanneau E, Jan M, Lachuer J, Trouillas J, Hypopronos (2010) Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up. J Clin Endocrinol Metab 95:1708\u20131716","journal-title":"J Clin Endocrinol Metab"},{"key":"2762_CR43","first-page":"1","volume":"65","author":"W Saeger","year":"1996","unstructured":"Saeger W (1996) Current pathological classification of pituitary adenomas. Acta Neurochir Suppl 65:1\u20133","journal-title":"Acta Neurochir Suppl"},{"key":"2762_CR44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/eje.1.02326","volume":"156","author":"W Saeger","year":"2007","unstructured":"Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156:203\u2013216","journal-title":"Eur J Endocrinol"},{"key":"2762_CR45","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1507\/endocrj.45.529","volume":"45","author":"N Saeki","year":"1998","unstructured":"Saeki N, Nakamura M, Sunami K, Yamaura A (1998) Surgical indication after bromocriptine therapy on giant prolactinomas: effects and limitations of the medical treatment. Endocr J 45:529\u2013537","journal-title":"Endocr J"},{"key":"2762_CR46","first-page":"152","volume":"26","author":"B Schaller","year":"2005","unstructured":"Schaller B (2005) Gender-related differences in prolactinomas. A clinicopathological study. Neuro Endocrinol Lett 26:152\u2013159","journal-title":"Neuro Endocrinol Lett"},{"key":"2762_CR47","doi-asserted-by":"crossref","unstructured":"Schwartz TH, Stieg PE, Anand VK (2006) Endoscopic transsphenoidal pituitary surgery with intraoperative magnetic resonance imaging. Neurosurgery 58:ONS44-51","DOI":"10.1227\/01.NEU.0000193927.49862.B6"},{"key":"2762_CR48","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/EJE-06-0646","volume":"156","author":"I Shimon","year":"2007","unstructured":"Shimon I, Benbassat C, Hadani M (2007) Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men. Eur J Endocrinol 156:225\u2013231","journal-title":"Eur J Endocrinol"},{"key":"2762_CR49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3171\/jns.2002.97.2.0299","volume":"97","author":"RK Shrivastava","year":"2002","unstructured":"Shrivastava RK, Arginteanu MS, King WA, Post KD (2002) Giant prolactinomas: clinical management and long-term follow up. J Neurosurg 97:299\u2013306","journal-title":"J Neurosurg"},{"key":"2762_CR50","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/00006123-199810000-00005","volume":"43","author":"R Steinmeier","year":"1998","unstructured":"Steinmeier R, Fahlbusch R, Ganslandt O, Nimsky C, Buchfelder M, Kaus M, Heigl T, Lenz G, Kuth R, Huk W (1998) Intraoperative magnetic resonance imaging with the magnetom open scanner: concepts, neurosurgical indications, and procedures: a preliminary report. Neurosurgery 43:739\u2013747","journal-title":"Neurosurgery"},{"key":"2762_CR52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11060-010-0459-3","volume":"104","author":"MS Yang","year":"2011","unstructured":"Yang MS, Hong JW, Lee SK, Lee EJ, Kim SH (2011) Clinical management and outcome of 36 invasive prolactinomas treated with dopamine agonist. J Neurooncol 104:195\u2013204","journal-title":"J Neurooncol"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-016-2762-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00701-016-2762-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-016-2762-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:21:15Z","timestamp":1559103675000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00701-016-2762-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,12]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["2762"],"URL":"https:\/\/doi.org\/10.1007\/s00701-016-2762-z","relation":{},"ISSN":["0001-6268","0942-0940"],"issn-type":[{"value":"0001-6268","type":"print"},{"value":"0942-0940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,12]]}}}